Paloma Partners Management CO Ultragenyx Pharmaceutical Inc. Transaction History

Paloma Partners Management CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$106.9 - $167.73 $447,055 - $701,446	-4,182 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$84.4 - $177.39 $352,960 - $741,844	4,182 New	4,182 $579,000
Q1 2020 May 15, 2020	SELL	$33.8 - $62.9 $633,614 - $1.18 Million	-18,746 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.08 - $45.83 $676,355 - $859,129	18,746 New	18,746 $801,000
Q4 2018 Feb 14, 2019	SELL	$38.89 - $77.3 $174,771 - $347,386	-4,494 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$71.81 - $90.15 $322,714 - $405,134	4,494 New	4,494 $343,000
Q2 2018 Aug 14, 2018	SELL	$48.54 - $85.31 $490,011 - $861,204	-10,095 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$44.33 - $58.52 $106,436 - $140,506	-2,401 Reduced 19.21%	10,095 $514,000
Q4 2017 Feb 14, 2018	BUY	$43.54 - $57.32 $544,075 - $716,270	12,496	12,496 $580,000

329

85.9M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.18B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.